Question 1

What is AilsynBio?

Accepted Answer

AilsynBio is a Entity.

Question 2

How often does AilsynBio appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 8 articles.

Question 3

When was AilsynBio first tracked by Ergen?

Accepted Answer

First tracked on Apr 10, 2026.

Question 4

When was AilsynBio last mentioned in news?

Accepted Answer

Last active on May 14, 2026.

Question 5

What is AilsynBio's current news sentiment?

Accepted Answer

Aggregate sentiment score: 70 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is AilsynBio in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving AilsynBio?

Accepted Answer

AilsynBio, Dong-E-E-Jiao AI-TCM Partnership (Apr 10, 2026, 8 articles).

Question 8

How did the "AilsynBio, Dong-E-E-Jiao AI-TCM Partnership" event impact AilsynBio?

Accepted Answer

AilsynBio, an AI-driven drug discovery company, signed a project cooperation agreement with Dong-E-E-Jiao Co., Ltd. to integrate AI with traditional medicine, aiming to accelerate biopharmaceutical R&D and explore new paradigms in healthcare.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.